<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01371695</url>
  </required_header>
  <id_info>
    <org_study_id>onc11-03-164</org_study_id>
    <nct_id>NCT01371695</nct_id>
  </id_info>
  <brief_title>Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer</brief_title>
  <official_title>Phase 1 of Serum IGF II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Onconix, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Onconix, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Insulin-like Growth Factor II is elevated
      sufficiently to detect Cervical Intraepithelial Neoplasia II (CIN II), Cervical
      Intraepithelial Neoplasia III (CIN III), and cervical cancer.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">September 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">60</enrollment>
  <condition>Cervical Cancer</condition>
  <condition>Cervical Intraepithelial Neoplasia II</condition>
  <condition>Cervical Intraepithelial Neoplasia III</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      frozen serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        university clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 - 75 years

          -  Female

          -  Normal medical history

          -  Medical history of a single type of cancer confirmed by biopsy or equivalent criteria

          -  Squamous cell carcinoma of organs other than cervix

          -  Adenocarcinoma

          -  Medical history of inflammatory disease

          -  May be pregnant

          -  Pap smear positive for Cervical Intraepithelial Neoplasia II or III

          -  Squamous cell cervical cancer confirmed by biopsy

          -  Informed consent

          -  Willingness to submit a blood sample by venipuncture

          -  Willingness to submit a second blood sample if necessary

        Exclusion Criteria:

          -  Age &lt; 18 or &gt; 75 years

          -  Medical history of cancer other than cervical cancer, Non-islet-cell tumor
             hypoglycemia, Growth hormone deficiency, Acromegaly, Hepatoma, inflammatory disease in
             addition to confirmed CIN and cervical cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Georgia Health Sciences</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2011</study_first_submitted>
  <study_first_submitted_qc>June 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2011</study_first_posted>
  <last_update_submitted>June 10, 2011</last_update_submitted>
  <last_update_submitted_qc>June 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2011</last_update_posted>
  <responsible_party>
    <name_title>Sharad A. Ghamande</name_title>
    <organization>Georgia Health Sciences University</organization>
  </responsible_party>
  <keyword>IGF-II levels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Carcinoma in Situ</mesh_term>
    <mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
    <mesh_term>Uterine Cervical Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

